XBRL Cloud: Business Report

Rendering

Component: (Network and Table)
Network	100290 - Disclosure - Income Taxes (Tables) (http://www.albireopharma.com/20161231/taxonomy/role/DisclosureIncomeTaxesTables)
Table	(Implied)

Slicers (applies to each fact value in each table cell)

Reporting Entity [Axis]

0001322505 (http://www.sec.gov/CIK)

Income Tax Disclosure [Abstract]

Period [Axis]

2016-01-01 - 2016-12-31

Income Tax Disclosure [Abstract]

Schedule of Components of Loss Before Income Taxes

For the years ended December 31, 2016 and 2015, the components of loss before income taxes were as follows (in thousands):

	Year Ended December 31,
	2016			2015
U.S.	$	(5,555	)	$	(69	)
Foreign		(10,733	)		(6,699	)
Total	$	(16,288	)	$	(6,768	)

Schedule of Components of Income Tax (Benefit)

The components of income tax (benefit) for the years ended December 31, 2016 and 2015 were as follows (in thousands):

	Year Ended December 31,
	2016			2015
Current tax expense:
Federal	$	50			—
State	$	12			—
Foreign		—			3
Total	$	62		$	3
Deferred tax benefit:
Federal	$	—		$	—
State		—			—
Foreign		—			(3)
Total	$	—		$	(3)
Total provision for income taxes	$	62		$	—
Effective tax rate		0	%		0	%

Schedule of Reconciliations of Statutory Income Tax Rate to Consolidated Effective Income Tax Rate

A reconciliation of the U.S. statutory income tax rate to the consolidated effective income tax rate was as follows:

	Year Ended December 31,
	2016			2015
U.K. statutory income tax rate		—			20 %
U.S. statutory income tax rate		34	%		—
Non-deductible interest expense		(6	%)		(2%)
Kreos warrant replacement		(2	%)		—
Other permanent differences		(1	%)		—
State taxes, net of federal tax effect		2	%		—
Increase in valuation allowance		(20	%)		(18	%)
Foreign tax rate differences		(7	%)		—
Effective income tax rate		0.0	%		0.0	%

Schedule of Tax Effect of Temporary Differences To Significant Portions of Deferred Tax Assets

Deferred taxes are recognized for temporary differences between the bases of assets and liabilities for financial statement and income tax purposes. The tax effect of temporary differences that give rise to significant portions of the deferred tax assets are as follows (in thousands):

	Year Ended December 31,
	2016			2015
Deferred tax assets:
Tax loss carryforwards	$	15,420		$	2,740
Capitalized expenses		36,254			—
Research and development credits		140			—
Accrued expenses		1,088			19
Stock compensation		383			—
Other		43			—
Total gross deferred tax assets		53,328			2,759
Valuation allowance		(53,257	)		(2,661	)
Total deferred tax assets		71			98
Deferred tax liabilities:
Intangible assets	$	40		$	—
Temporary difference on financial instruments		31			98
Total deferred tax liabilities		71			98
Net deferred tax assets	$	—		$	—

Schedule of Components of Total Net Deferred Taxes

Total net deferred taxes are classified as follows (in thousands):

	As of December 31,
	2016		2015
Noncurrent deferred tax assets	$	—	$	—
Noncurrent deferred tax liabilities		—		—

Summary of Activity Related to Company's Liabilities for Uncertain Tax Positions

The following table summarized the activity related to the Company's liabilities for uncertain tax positions:

	Year Ended December 31,
	2016		2015
Balance, beginning of year	$	—	$	—
Decrease related to prior year's tax position		—		—
Balance, at end of year	$	—	$	—